federal_register: 2021-28051
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-28051 | Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers; Guidance for Industry; Availability | Notice | The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers." This guidance represents FDA's current thinking on the management and conduct of pathology peer review performed during good laboratory practice (GLP)-compliant toxicology studies. This guidance finalizes the draft guidance "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers" issued on September 30, 2019. This revision includes editorial changes to improve the clarity of the document. | 2021-12-27 | 2021 | 12 | https://www.federalregister.gov/documents/2021/12/27/2021-28051/pathology-peer-review-in-nonclinical-toxicology-studies-questions-and-answers-guidance-for-industry | https://www.govinfo.gov/content/pkg/FR-2021-12-27/pdf/2021-28051.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers." This guidance represents FDA's current thinking... |